Episode

Reimagining Longevity: DR. ADEEL KHAN on Muse Cells & the Future of Regenerative Medicine

Podcast: Tech, Innovation & Society - The Creative Process: Technology, AI, Software, Future, Economy, Science, Engineering & Robotics Interviews
Published: Jan 23, 2026
Duration seconds: 2892
Processing state: processed
Canonical source: https://www.creativeprocess.info/technology-innovation-society/adeel-khan
Audio: https://static1.squarespace.com/static/5745d9f137013b9d0a627c60/t/697605baf8f9c07d0716ed5e/1769342449354/adeel-khan-the-creative-process-podcast-FULL.mp3
JSON: /v1/public/podcasts/tech-innovation-and-society/episodes/reimagining-longevity-dr-adeel-khan-on-muse-cells-the-future-of-regenerative-medicine
Markdown: /podcast/tech-innovation-and-society/reimagining-longevity-dr-adeel-khan-on-muse-cells-the-future-of-regenerative-medicine.md

Actions

POST https://stenobird.com/v1/public/podcasts/tech-innovation-and-society/episodes/reimagining-longevity-dr-adeel-khan-on-muse-cells-the-future-of-regenerative-medicine/transcription-requests
Idempotently request low-priority transcript generation for this episode.
GET https://stenobird.com/podcast/tech-innovation-and-society/reimagining-longevity-dr-adeel-khan-on-muse-cells-the-future-of-regenerative-medicine.md
Read the agent-friendly Markdown representation of this episode resource.

Summary

Dr. Adeel Khan explains how MUSE cells offer a safer, pluripotent alternative to traditional stem cell therapies for true tissue regeneration. The discussion explores the transition from managing chronic symptoms to actively reversing disease through advanced regenerative medicine.

Topics

Regenerative Medicine
MUSE Cells
Stem Cell Therapy
Longevity
Biotechnology
Pluripotency
Autoimmune Disease
Tissue Engineering

Highlights

Main idea: MUSE cells are pluripotent and capable of creating new tissue, unlike standard MSCs which primarily reduce inflammation
Practical takeaway: True regenerative therapy requires standardized cell populations rather than simple umbilical cord injections
Failure mode: Many clinics market 'stem cell' procedures that are actually just anti-inflammatory injections, failing to provide actual repair
Future outlook: The integration of stem cells, gene therapy, and fecal microbial transplants could cure autoimmune diseases within a decade
Safety note: MUSE cells provide pluripotency without the cancer risks associated with traditional Yamanaka factor reprogramming

Chapters

1:00 The Shift in Regenerative Medicine: Dr. Khan introduces the transition from symptom management to active tissue repair using advanced cell therapies.
4:40 Standardizing Cell Populations: The technical challenges of isolating specific, high-quality cell populations for consistent therapeutic results.
8:20 Limitations of Current Treatments: A comparison between traditional cortisone and PRP injections versus true regenerative cell therapy.
12:00 The Democratization of Innovation: How advanced medical technologies move from elite accessibility to the broader public through economies of scale.
15:40 Frequency and Biological Impact: Discussing the importance of dosing frequency and the biological response to cell-based interventions.
19:10 Clinical Trials and FDA Pathways: The progress of phase trials for heart attack recovery and the regulatory roadmap for US approval.
22:50 Navigating the Regulatory Landscape: Warning against unregulated clinics and the importance of informed decision-making in stem cell procedures.